EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for

Dosimetry Iodine-131 Molecular radiotherapy Neuroblastoma Neuroendocrine mIBG

Journal

EJNMMI physics
ISSN: 2197-7364
Titre abrégé: EJNMMI Phys
Pays: Germany
ID NLM: 101658952

Informations de publication

Date de publication:
06 Mar 2020
Historique:
received: 10 12 2019
accepted: 13 02 2020
entrez: 8 3 2020
pubmed: 8 3 2020
medline: 8 3 2020
Statut: epublish

Résumé

The purpose of the EANM Dosimetry Committee Series on "Standard Operational Procedures for Dosimetry" (SOP) is to provide advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This SOP describes image and data acquisition parameters and dosimetry calculations to determine the absorbed doses delivered to whole-body, tumour and normal organs following a therapeutic administration of

Identifiants

pubmed: 32144574
doi: 10.1186/s40658-020-0282-7
pii: 10.1186/s40658-020-0282-7
pmc: PMC7060302
doi:

Types de publication

Journal Article

Langues

eng

Pagination

15

Références

J Nucl Med. 1978 May;19(5):538-44
pubmed: 641578
J Clin Oncol. 1992 Dec;10(12):1889-96
pubmed: 1453204
Phys Med Biol. 2012 Jan 21;57(2):517-33
pubmed: 22217735
Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47
pubmed: 18274745
Mol Imaging Biol. 2015 Apr;17(2):284-94
pubmed: 25145966
Cancer Biother Radiopharm. 2005 Feb;20(1):66-71
pubmed: 15778583
Eur J Cancer. 1998 Aug;34(9):1398-402
pubmed: 9849423
Med Phys. 2015 Jul;42(7):3969-78
pubmed: 26133597
J Nucl Med. 2013 Dec;54(12):2182-8
pubmed: 24130233
Nucl Med Commun. 2012 Dec;33(12):1254-66
pubmed: 23010981
Radiother Oncol. 2005 Dec;77(3):301-9
pubmed: 16274763
Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S10-8
pubmed: 21484385
J Clin Oncol. 2004 Jun 15;22(12):2452-60
pubmed: 15197208
Phys Med Biol. 2016 Mar 21;61(6):2532-51
pubmed: 26948833
Ann Nucl Med. 1994 Nov;8(4):259-68
pubmed: 7702971
Br J Cancer. 1999 Dec;81(8):1378-84
pubmed: 10604736
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2456-2474
pubmed: 30218316
J Nucl Med. 1984 Feb;25(2):197-206
pubmed: 6726430
J Nucl Med. 1996 Jun;37(6):1058-63
pubmed: 8683301
Semin Nucl Med. 2011 Sep;41(5):324-33
pubmed: 21803182
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1037-48
pubmed: 19288099
J Nucl Med. 2005 May;46(5):840-9
pubmed: 15872359
EJNMMI Res. 2014 Dec;4(1):67
pubmed: 26116127
Cancer Biother Radiopharm. 2005 Apr;20(2):195-9
pubmed: 15869455
J Nucl Med. 2010 Apr;51(4):654-9
pubmed: 20237032
IEEE Trans Med Imaging. 1991;10(3):408-12
pubmed: 18222843
Med Phys. 1998 Jan;25(1):85-91
pubmed: 9472830
EJNMMI Phys. 2017 Dec 04;4(1):28
pubmed: 29199391
Q J Nucl Med Mol Imaging. 2011 Apr;55(2):116-25
pubmed: 21386786
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
J Nucl Med. 2000 Oct;41(10):1760-7
pubmed: 11038009
Br J Cancer. 2015 Feb 17;112(4):644-9
pubmed: 25602966
Br J Radiol. 1992 Sep;65(777):787-91
pubmed: 1393416
Health Phys. 2003 Sep;85(3):294-310
pubmed: 12938720
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1238-50
pubmed: 20411259
J Nucl Med. 2015 Nov;56(11):1800-3
pubmed: 26338897
J Nucl Med. 2001 Nov;42(11):1713-21
pubmed: 11696644
J Nucl Med. 2009 Feb;50(2):316-23
pubmed: 19164237
Cancer Biother Radiopharm. 2007 Feb;22(1):105-12
pubmed: 17627418
J Clin Oncol. 2007 Mar 20;25(9):1054-60
pubmed: 17369569
Phys Med Biol. 2002 Sep 7;47(17):3211-23
pubmed: 12361219
J Nucl Med. 2009 Sep;50(9):1518-24
pubmed: 19713562
Med Phys. 2007 Nov;34(11):4285-92
pubmed: 18072493
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1225-31
pubmed: 20411257
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):192-200
pubmed: 20799035
Nucl Med Commun. 2013 Mar;34(3):240-8
pubmed: 23276830
J Nucl Med. 2000 Jan;41(1):149-60
pubmed: 10647618
Cancer Biother Radiopharm. 2007 Apr;22(2):243-9
pubmed: 17600471
EJNMMI Phys. 2018 Jan 11;5(1):2
pubmed: 29322344
Cancer Biother Radiopharm. 2003 Feb;18(1):99-107
pubmed: 12667313
Cancer Biother Radiopharm. 2003 Feb;18(1):81-7
pubmed: 12667311
Q J Nucl Med Mol Imaging. 2013 Jun;57(2):161-70
pubmed: 23822991
Phys Med Biol. 1998 Aug;43(8):2309-23
pubmed: 9725606

Auteurs

Jonathan Gear (J)

Joint Department of Physics, Royal Marsden Hospital & Institute of Cancer Research, Sutton, UK. jgear@icr.ac.uk.

Carlo Chiesa (C)

Nuclear Medicine, Foundation IRCCS Istituto Nazionale Tumori, Milan, Italy.

Michael Lassmann (M)

Department of Nuclear Medicine, University of Würzburg, 97080, Würzburg, Germany.

Pablo Mínguez Gabiña (PM)

Department of Medical Physics and Radiation Protection, Gurutzeta/Cruces University Hospital, Barakaldo, Spain.

Johannes Tran-Gia (J)

Department of Nuclear Medicine, University of Würzburg, 97080, Würzburg, Germany.

Caroline Stokke (C)

Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Glenn Flux (G)

Joint Department of Physics, Royal Marsden Hospital & Institute of Cancer Research, Sutton, UK.

Classifications MeSH